Expert Session Sheds Light on Flow Cytometry in Lymphoma Diagnosis

Published on: August 10, 2024

The Department of Pathology at Swami Rama Himalayan University organized an insightful guest lecture by Dr. Prashant Tembhare, Professor at the Department of Hematopathology, ACTREC, Tata Memorial Hospital, Mumbai, on August 10, 2024. The session was part of a broader academic series titled “Hematology Insights: From Coagulation to Cytometry.”

Addressing an audience of approximately 120 participants, Dr. Tembhare focused on the crucial role of flow cytometry in the diagnosis and classification of various lymphomas. The lecture provided a deep dive into the sample processing techniques and analytical protocols essential for effective cytometric analysis.

Dr. Tembhare elaborated on the processing of different specimen types, including peripheral blood (PB), bone marrow aspirate (BMA), cerebrospinal fluid (CSF), pleural fluid (PF), and bronchoalveolar lavage (BAL), which already exist in a suspended cell state. He also explained the specialized methods required to process solid tissues—such as slicing, mincing, teasing, and filtering—to prepare viable single-cell suspensions suitable for flow cytometric evaluation.

An important segment of the lecture addressed sample stabilization practices. Dr. Tembhare emphasized using anticoagulants like EDTA or Heparin to prevent clotting in blood samples and RPMI media to preserve the viability of cells in fluid specimens and fine needle aspiration cytology (FNAC) samples.

The lecture also touched upon the significance of identifying specific marker expressions to distinguish between B-cell and T-cell Non-Hodgkin Lymphomas (NHL), underscoring the diagnostic precision that flow cytometry brings to hematopathology.

The event proved to be a rich academic experience, enhancing participants’ understanding of cutting-edge diagnostic methodologies. It concluded with an interactive Q&A session, where attendees engaged in meaningful dialogue, reflecting the practical impact and relevance of the session to clinical and research settings.

Picture1
   Admissions Form         

Admission Open For 2025

×
International Endowed Chair Professor

Prof Rakesh Kumar

Prof Rakesh Kumar is the Founder and President of the Breast Cancer in Young Women Foundation (USA), dedicated to vaddressing the distinct issues affecting young women with breast cancer. He also serves as the International Endowed Chair Professor at the Cancer Research Institute of the Himalayan Institute of Medical Sciences. Additionally, he holds adjunct professorships at Rutgers New Jersey Medical School and Virginia Commonwealth University.

Dr Kumar earned his Ph.D. from the All India Institute of Medical Sciences in 1984 and began his research career at Memorial Sloan Kettering Cancer Center in January 1986. From 1988 to 2017, he held various academic and leadership positions —including faculty member, tenured professor, distinguished professor, endowed chair, department chair, and research leader—at esteemed institutions such as Memorial Sloan Kettering Cancer Center in New York and the University of Texas MD Anderson Cancer Center in Houston. From 2017 to 2022, he served as the National Chair for Cancer Research for the Government of India and as a distinguished professor, continuing his innovative work in breast cancer research.

With nearly 40 years of research and professional experience, Dr. Kumar has made conceptual contributions to the field of cancer research (h-index 108, citations >50,000). He has authored over 325 peer-reviewed publications, edited or co-edited nine books, and delivered 290 invited lectures worldwide. His work has been featured on the covers of 18 major cancer journals and has been highlighted in institutional research reports of the MD Anderson Cancer Center.

A passionate educator and mentor, Dr. Kumar has guided 67 trainees throughout his career. He serves on the editorial boards of multiple leading cancer journals and has served on the editorial boards of 21 top cancer journals. His global reputation is further demonstrated by his participation in about 100 peer-review panels for cancer research funding in the US and internationally over the past 28 years.

Dr. Kumar's innovative research has earned him numerous prestigious honors, including the Hinkle Society Faculty Award at Penn State University (1994), the Dalla/Fort Worth Living Legend Faculty Achievement Award in Basic Sciences (2004), the Ranbaxy Research Award (2006), and the Lifetime Achievement Award from the American Association of Indian Scientists in Cancer Research (2013), among others. Dr. Kumar's pioneering research continues to have a profound influence on the fields of oncology and breast cancer, opening up new opportunities for biomedical scientists and trainees worldwide.